0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pseudoephedrine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-35T1901
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pseudoephedrine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pseudoephedrine Market Research Report 2025

Code: QYRE-Auto-35T1901
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pseudoephedrine Market

The global market for Pseudoephedrine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pseudoephedrine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pseudoephedrine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pseudoephedrine in Sinusitis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pseudoephedrine include Pfizer (Wyeth), Endo International, Sanofi, Hanmi, Merck, Cypress Pharma, Johnson & Johnson, Kroger Company, CVS Caremark, Ratiopharm (Teva), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pseudoephedrine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pseudoephedrine.
The Pseudoephedrine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pseudoephedrine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pseudoephedrine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pseudoephedrine Market Report

Report Metric Details
Report Name Pseudoephedrine Market
Segment by Type
  • Active Pharmaceutical Ingredients
  • Preparation
Segment by Application
  • Sinusitis
  • Congestive Rhinitis
  • Bronchial Asthma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer (Wyeth), Endo International, Sanofi, Hanmi, Merck, Cypress Pharma, Johnson & Johnson, Kroger Company, CVS Caremark, Ratiopharm (Teva), UCB, Inc, Pacific Pharmal, Sun Pharmaceutical, Apotec, Zhuhai Tianda Pharma, Sichuan Shenghe Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pseudoephedrine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pseudoephedrine Market report?

Ans: The main players in the Pseudoephedrine Market are Pfizer (Wyeth), Endo International, Sanofi, Hanmi, Merck, Cypress Pharma, Johnson & Johnson, Kroger Company, CVS Caremark, Ratiopharm (Teva), UCB, Inc, Pacific Pharmal, Sun Pharmaceutical, Apotec, Zhuhai Tianda Pharma, Sichuan Shenghe Pharmaceutical

What are the Application segmentation covered in the Pseudoephedrine Market report?

Ans: The Applications covered in the Pseudoephedrine Market report are Sinusitis, Congestive Rhinitis, Bronchial Asthma, Other

What are the Type segmentation covered in the Pseudoephedrine Market report?

Ans: The Types covered in the Pseudoephedrine Market report are Active Pharmaceutical Ingredients, Preparation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudoephedrine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Active Pharmaceutical Ingredients
1.2.3 Preparation
1.3 Market by Application
1.3.1 Global Pseudoephedrine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Sinusitis
1.3.3 Congestive Rhinitis
1.3.4 Bronchial Asthma
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pseudoephedrine Market Perspective (2020-2031)
2.2 Global Pseudoephedrine Growth Trends by Region
2.2.1 Global Pseudoephedrine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pseudoephedrine Historic Market Size by Region (2020-2025)
2.2.3 Pseudoephedrine Forecasted Market Size by Region (2026-2031)
2.3 Pseudoephedrine Market Dynamics
2.3.1 Pseudoephedrine Industry Trends
2.3.2 Pseudoephedrine Market Drivers
2.3.3 Pseudoephedrine Market Challenges
2.3.4 Pseudoephedrine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pseudoephedrine Players by Revenue
3.1.1 Global Top Pseudoephedrine Players by Revenue (2020-2025)
3.1.2 Global Pseudoephedrine Revenue Market Share by Players (2020-2025)
3.2 Global Pseudoephedrine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pseudoephedrine Revenue
3.4 Global Pseudoephedrine Market Concentration Ratio
3.4.1 Global Pseudoephedrine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudoephedrine Revenue in 2024
3.5 Global Key Players of Pseudoephedrine Head office and Area Served
3.6 Global Key Players of Pseudoephedrine, Product and Application
3.7 Global Key Players of Pseudoephedrine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pseudoephedrine Breakdown Data by Type
4.1 Global Pseudoephedrine Historic Market Size by Type (2020-2025)
4.2 Global Pseudoephedrine Forecasted Market Size by Type (2026-2031)
5 Pseudoephedrine Breakdown Data by Application
5.1 Global Pseudoephedrine Historic Market Size by Application (2020-2025)
5.2 Global Pseudoephedrine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pseudoephedrine Market Size (2020-2031)
6.2 North America Pseudoephedrine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pseudoephedrine Market Size by Country (2020-2025)
6.4 North America Pseudoephedrine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pseudoephedrine Market Size (2020-2031)
7.2 Europe Pseudoephedrine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pseudoephedrine Market Size by Country (2020-2025)
7.4 Europe Pseudoephedrine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pseudoephedrine Market Size (2020-2031)
8.2 Asia-Pacific Pseudoephedrine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pseudoephedrine Market Size by Region (2020-2025)
8.4 Asia-Pacific Pseudoephedrine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pseudoephedrine Market Size (2020-2031)
9.2 Latin America Pseudoephedrine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pseudoephedrine Market Size by Country (2020-2025)
9.4 Latin America Pseudoephedrine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pseudoephedrine Market Size (2020-2031)
10.2 Middle East & Africa Pseudoephedrine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pseudoephedrine Market Size by Country (2020-2025)
10.4 Middle East & Africa Pseudoephedrine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer (Wyeth)
11.1.1 Pfizer (Wyeth) Company Details
11.1.2 Pfizer (Wyeth) Business Overview
11.1.3 Pfizer (Wyeth) Pseudoephedrine Introduction
11.1.4 Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2020-2025)
11.1.5 Pfizer (Wyeth) Recent Development
11.2 Endo International
11.2.1 Endo International Company Details
11.2.2 Endo International Business Overview
11.2.3 Endo International Pseudoephedrine Introduction
11.2.4 Endo International Revenue in Pseudoephedrine Business (2020-2025)
11.2.5 Endo International Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pseudoephedrine Introduction
11.3.4 Sanofi Revenue in Pseudoephedrine Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Hanmi
11.4.1 Hanmi Company Details
11.4.2 Hanmi Business Overview
11.4.3 Hanmi Pseudoephedrine Introduction
11.4.4 Hanmi Revenue in Pseudoephedrine Business (2020-2025)
11.4.5 Hanmi Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Pseudoephedrine Introduction
11.5.4 Merck Revenue in Pseudoephedrine Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Cypress Pharma
11.6.1 Cypress Pharma Company Details
11.6.2 Cypress Pharma Business Overview
11.6.3 Cypress Pharma Pseudoephedrine Introduction
11.6.4 Cypress Pharma Revenue in Pseudoephedrine Business (2020-2025)
11.6.5 Cypress Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Pseudoephedrine Introduction
11.7.4 Johnson & Johnson Revenue in Pseudoephedrine Business (2020-2025)
11.7.5 Johnson & Johnson Recent Development
11.8 Kroger Company
11.8.1 Kroger Company Company Details
11.8.2 Kroger Company Business Overview
11.8.3 Kroger Company Pseudoephedrine Introduction
11.8.4 Kroger Company Revenue in Pseudoephedrine Business (2020-2025)
11.8.5 Kroger Company Recent Development
11.9 CVS Caremark
11.9.1 CVS Caremark Company Details
11.9.2 CVS Caremark Business Overview
11.9.3 CVS Caremark Pseudoephedrine Introduction
11.9.4 CVS Caremark Revenue in Pseudoephedrine Business (2020-2025)
11.9.5 CVS Caremark Recent Development
11.10 Ratiopharm (Teva)
11.10.1 Ratiopharm (Teva) Company Details
11.10.2 Ratiopharm (Teva) Business Overview
11.10.3 Ratiopharm (Teva) Pseudoephedrine Introduction
11.10.4 Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2020-2025)
11.10.5 Ratiopharm (Teva) Recent Development
11.11 UCB, Inc
11.11.1 UCB, Inc Company Details
11.11.2 UCB, Inc Business Overview
11.11.3 UCB, Inc Pseudoephedrine Introduction
11.11.4 UCB, Inc Revenue in Pseudoephedrine Business (2020-2025)
11.11.5 UCB, Inc Recent Development
11.12 Pacific Pharmal
11.12.1 Pacific Pharmal Company Details
11.12.2 Pacific Pharmal Business Overview
11.12.3 Pacific Pharmal Pseudoephedrine Introduction
11.12.4 Pacific Pharmal Revenue in Pseudoephedrine Business (2020-2025)
11.12.5 Pacific Pharmal Recent Development
11.13 Sun Pharmaceutical
11.13.1 Sun Pharmaceutical Company Details
11.13.2 Sun Pharmaceutical Business Overview
11.13.3 Sun Pharmaceutical Pseudoephedrine Introduction
11.13.4 Sun Pharmaceutical Revenue in Pseudoephedrine Business (2020-2025)
11.13.5 Sun Pharmaceutical Recent Development
11.14 Apotec
11.14.1 Apotec Company Details
11.14.2 Apotec Business Overview
11.14.3 Apotec Pseudoephedrine Introduction
11.14.4 Apotec Revenue in Pseudoephedrine Business (2020-2025)
11.14.5 Apotec Recent Development
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Details
11.15.2 Zhuhai Tianda Pharma Business Overview
11.15.3 Zhuhai Tianda Pharma Pseudoephedrine Introduction
11.15.4 Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2020-2025)
11.15.5 Zhuhai Tianda Pharma Recent Development
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Details
11.16.2 Sichuan Shenghe Pharmaceutical Business Overview
11.16.3 Sichuan Shenghe Pharmaceutical Pseudoephedrine Introduction
11.16.4 Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2020-2025)
11.16.5 Sichuan Shenghe Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pseudoephedrine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Active Pharmaceutical Ingredients
 Table 3. Key Players of Preparation
 Table 4. Global Pseudoephedrine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pseudoephedrine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pseudoephedrine Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pseudoephedrine Market Share by Region (2020-2025)
 Table 8. Global Pseudoephedrine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pseudoephedrine Market Share by Region (2026-2031)
 Table 10. Pseudoephedrine Market Trends
 Table 11. Pseudoephedrine Market Drivers
 Table 12. Pseudoephedrine Market Challenges
 Table 13. Pseudoephedrine Market Restraints
 Table 14. Global Pseudoephedrine Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pseudoephedrine Market Share by Players (2020-2025)
 Table 16. Global Top Pseudoephedrine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudoephedrine as of 2024)
 Table 17. Ranking of Global Top Pseudoephedrine Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pseudoephedrine Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pseudoephedrine, Headquarters and Area Served
 Table 20. Global Key Players of Pseudoephedrine, Product and Application
 Table 21. Global Key Players of Pseudoephedrine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pseudoephedrine Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pseudoephedrine Revenue Market Share by Type (2020-2025)
 Table 25. Global Pseudoephedrine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pseudoephedrine Revenue Market Share by Type (2026-2031)
 Table 27. Global Pseudoephedrine Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pseudoephedrine Revenue Market Share by Application (2020-2025)
 Table 29. Global Pseudoephedrine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pseudoephedrine Revenue Market Share by Application (2026-2031)
 Table 31. North America Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pseudoephedrine Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pseudoephedrine Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pseudoephedrine Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pseudoephedrine Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pseudoephedrine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pseudoephedrine Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pseudoephedrine Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pseudoephedrine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pseudoephedrine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pseudoephedrine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pseudoephedrine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer (Wyeth) Company Details
 Table 47. Pfizer (Wyeth) Business Overview
 Table 48. Pfizer (Wyeth) Pseudoephedrine Product
 Table 49. Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 50. Pfizer (Wyeth) Recent Development
 Table 51. Endo International Company Details
 Table 52. Endo International Business Overview
 Table 53. Endo International Pseudoephedrine Product
 Table 54. Endo International Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 55. Endo International Recent Development
 Table 56. Sanofi Company Details
 Table 57. Sanofi Business Overview
 Table 58. Sanofi Pseudoephedrine Product
 Table 59. Sanofi Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 60. Sanofi Recent Development
 Table 61. Hanmi Company Details
 Table 62. Hanmi Business Overview
 Table 63. Hanmi Pseudoephedrine Product
 Table 64. Hanmi Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 65. Hanmi Recent Development
 Table 66. Merck Company Details
 Table 67. Merck Business Overview
 Table 68. Merck Pseudoephedrine Product
 Table 69. Merck Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 70. Merck Recent Development
 Table 71. Cypress Pharma Company Details
 Table 72. Cypress Pharma Business Overview
 Table 73. Cypress Pharma Pseudoephedrine Product
 Table 74. Cypress Pharma Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 75. Cypress Pharma Recent Development
 Table 76. Johnson & Johnson Company Details
 Table 77. Johnson & Johnson Business Overview
 Table 78. Johnson & Johnson Pseudoephedrine Product
 Table 79. Johnson & Johnson Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 80. Johnson & Johnson Recent Development
 Table 81. Kroger Company Company Details
 Table 82. Kroger Company Business Overview
 Table 83. Kroger Company Pseudoephedrine Product
 Table 84. Kroger Company Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 85. Kroger Company Recent Development
 Table 86. CVS Caremark Company Details
 Table 87. CVS Caremark Business Overview
 Table 88. CVS Caremark Pseudoephedrine Product
 Table 89. CVS Caremark Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 90. CVS Caremark Recent Development
 Table 91. Ratiopharm (Teva) Company Details
 Table 92. Ratiopharm (Teva) Business Overview
 Table 93. Ratiopharm (Teva) Pseudoephedrine Product
 Table 94. Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 95. Ratiopharm (Teva) Recent Development
 Table 96. UCB, Inc Company Details
 Table 97. UCB, Inc Business Overview
 Table 98. UCB, Inc Pseudoephedrine Product
 Table 99. UCB, Inc Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 100. UCB, Inc Recent Development
 Table 101. Pacific Pharmal Company Details
 Table 102. Pacific Pharmal Business Overview
 Table 103. Pacific Pharmal Pseudoephedrine Product
 Table 104. Pacific Pharmal Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 105. Pacific Pharmal Recent Development
 Table 106. Sun Pharmaceutical Company Details
 Table 107. Sun Pharmaceutical Business Overview
 Table 108. Sun Pharmaceutical Pseudoephedrine Product
 Table 109. Sun Pharmaceutical Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 110. Sun Pharmaceutical Recent Development
 Table 111. Apotec Company Details
 Table 112. Apotec Business Overview
 Table 113. Apotec Pseudoephedrine Product
 Table 114. Apotec Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 115. Apotec Recent Development
 Table 116. Zhuhai Tianda Pharma Company Details
 Table 117. Zhuhai Tianda Pharma Business Overview
 Table 118. Zhuhai Tianda Pharma Pseudoephedrine Product
 Table 119. Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 120. Zhuhai Tianda Pharma Recent Development
 Table 121. Sichuan Shenghe Pharmaceutical Company Details
 Table 122. Sichuan Shenghe Pharmaceutical Business Overview
 Table 123. Sichuan Shenghe Pharmaceutical Pseudoephedrine Product
 Table 124. Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2020-2025) & (US$ Million)
 Table 125. Sichuan Shenghe Pharmaceutical Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Pseudoephedrine Picture
 Figure 2. Global Pseudoephedrine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pseudoephedrine Market Share by Type: 2024 VS 2031
 Figure 4. Active Pharmaceutical Ingredients Features
 Figure 5. Preparation Features
 Figure 6. Global Pseudoephedrine Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pseudoephedrine Market Share by Application: 2024 VS 2031
 Figure 8. Sinusitis Case Studies
 Figure 9. Congestive Rhinitis Case Studies
 Figure 10. Bronchial Asthma Case Studies
 Figure 11. Other Case Studies
 Figure 12. Pseudoephedrine Report Years Considered
 Figure 13. Global Pseudoephedrine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pseudoephedrine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pseudoephedrine Market Share by Region: 2024 VS 2031
 Figure 16. Global Pseudoephedrine Market Share by Players in 2024
 Figure 17. Global Top Pseudoephedrine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudoephedrine as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pseudoephedrine Revenue in 2024
 Figure 19. North America Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pseudoephedrine Market Share by Country (2020-2031)
 Figure 21. United States Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pseudoephedrine Market Share by Country (2020-2031)
 Figure 25. Germany Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pseudoephedrine Market Share by Region (2020-2031)
 Figure 33. China Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pseudoephedrine Market Share by Country (2020-2031)
 Figure 41. Mexico Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pseudoephedrine Market Share by Country (2020-2031)
 Figure 45. Turkey Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pseudoephedrine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer (Wyeth) Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 49. Endo International Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 50. Sanofi Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 51. Hanmi Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 52. Merck Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 53. Cypress Pharma Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 54. Johnson & Johnson Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 55. Kroger Company Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 56. CVS Caremark Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 57. Ratiopharm (Teva) Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 58. UCB, Inc Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 59. Pacific Pharmal Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 60. Sun Pharmaceutical Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 61. Apotec Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 62. Zhuhai Tianda Pharma Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 63. Sichuan Shenghe Pharmaceutical Revenue Growth Rate in Pseudoephedrine Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD